Introduction
Medical device registration in the United Kingdom is the structured regulatory and operational function through which a business determines whether a product qualifies as a medical device under the UK framework, satisfies the applicable conformity position for the relevant UK territory and completes the registration steps required before market placement.
In practical terms, the UK is not one single market architecture. Great Britain and Northern Ireland operate under different rule sets, and a business must understand whether it is targeting England, Wales and Scotland, Northern Ireland, or both before building its registration strategy.
The subject is commercially important because the UK remains a major health-technology market, while errors in territory mapping, conformity marking, responsible-person appointment or MHRA registration can block lawful placement on the market.
Home
└── Jurisdictions
└── United Kingdom
└── Medical Device Registration United Kingdom
Identity
- Object: Medical Device Registration
- Jurisdiction: United Kingdom
- Object ID: UK.MDR.001
- Reference: MAR-UK-MDR-001-A
Core Framework
- MHRA-centered registration and market surveillance
- UK MDR 2002 framework for Great Britain
- UK Responsible Person requirement for non-UK manufacturers placing devices on the Great Britain market
- Territory-sensitive rules for Great Britain and Northern Ireland
Operating Logic
- Registration before market placement in Great Britain
- Conformity marking and registration must be aligned
- UKCA and CE positioning depends on territory and transition rules
- Non-UK manufacturers need a UK Responsible Person for Great Britain
Executive Summary
Medical device registration in the United Kingdom is the professional regulatory and market-access function concerned with determining whether a product qualifies as a medical device under the UK framework, identifying the territory-specific route to market and completing the registration architecture required for lawful commercial placement.
The UK system must be analysed with territorial precision. Great Britain and Northern Ireland are not governed by exactly the same route-to-market logic. The MHRA’s guidance distinguishes the Great Britain framework from the Northern Ireland framework and states that different rules apply in Northern Ireland. [page:2]
For Great Britain, the MHRA states that all medical devices, including IVDs, custom-made devices and systems or procedure packs, must be registered with the MHRA before they are placed on the market, and that devices must conform to the UK MDR 2002 in order to be registered. [page:1][page:2]
For non-UK manufacturers placing devices on the Great Britain market, the MHRA states that a single UK Responsible Person must be appointed, and that this person assumes specified responsibilities, including registration on behalf of the manufacturer. [page:1][page:2]
The system also separates registration from approval rhetoric. MHRA guidance states that registration does not represent accreditation, certification, approval or endorsement by the MHRA, and businesses must not market it as though it does. [page:1]
| Definition | The professional regulatory and market-access function concerned with lawful placement of medical devices on the United Kingdom market through territory-aware conformity, representative structure and registration with the MHRA where required. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, United Kingdom, MHRA, UK Responsible Person, UKCA, CE, Great Britain, Northern Ireland, UK MDR 2002 |
| Jurisdiction | United Kingdom |
Definition
Medical device registration in the United Kingdom refers to the structured process through which a business determines whether its product falls within the UK medical-device framework, identifies the relevant territorial rule set, confirms the conformity and representative model and completes the registration steps required to place the device lawfully on the intended UK market.
The object is broader than a portal filing. It covers product qualification, classification logic, conformity route, territory split, UK Responsible Person analysis where relevant, registration readiness, documentation discipline and post-registration maintenance.
| Covered Matters | Device qualification, UK territory mapping, Great Britain versus Northern Ireland rule analysis, conformity route, UK Responsible Person structure, MHRA registration and continuing registration maintenance. |
| Functional Boundary | The Registry Object covers the work needed to lawfully place a medical device on the relevant UK market segment. |
| Related but Not Primary | Public procurement, reimbursement, patent strategy, NHS sales channels and general commercial distribution agreements are adjacent but not the primary object here. |
| Outside Scope | Pharmaceutical regulation, unrelated product sectors, general company formation and pure marketing strategy unrelated to device lawfulness. |
Scope
The UK medical device registration function applies to devices intended for the Great Britain market, the Northern Ireland market, or both, but the exact obligations differ depending on territory, classification, conformity route, manufacturer location and representative model.
The MHRA states that Great Britain is England, Wales and Scotland, while different rules apply in Northern Ireland under the Northern Ireland Regulations 2021. [page:2]
Editorial Note: A UK medical device registration review is incomplete if it does not distinguish Great Britain from Northern Ireland at the beginning of the analysis. [page:1][page:2]
Purpose
The purpose of medical device registration in the United Kingdom is to convert a product, technical file and commercial plan into a lawful UK market-entry position.
In business terms, the function exists to determine the correct territorial path, identify the right conformity and representation model, complete MHRA registration where required and avoid market-placement errors caused by assuming the UK is a single undifferentiated regulatory space.
Primary Outcome
A coherent UK medical device registration position means that the business has identified the relevant market territory, aligned the conformity basis, appointed a UK Responsible Person where required for Great Britain and completed the registration position needed for lawful supply.
For Great Britain, the primary outcome generally includes confirmed conformity under the applicable framework and successful MHRA registration before placement on the market. [page:1][page:2]
Request Contexts
Request contexts show the practical business events that trigger UK medical device registration work. Many arise when a foreign manufacturer is entering Great Britain or when a business needs to distinguish Great Britain and Northern Ireland obligations.
| Identity Pattern | Manufacturer planning UK entry, non-UK manufacturer needing a UK Responsible Person, regulatory lead mapping Great Britain versus Northern Ireland strategy, device company validating conformity and registration sequence. |
| Business Event | First UK launch, territory expansion, registration update, change of UK Responsible Person, conformity marking review, transition planning for CE or UKCA positioning, or post-acquisition device portfolio review. |
| Typical User | Manufacturers, regulatory affairs managers, UK Responsible Persons, legal advisers, distributors, import-oriented commercial teams and international medtech businesses. |
| Typical Scenario | A company wants to place a device on the Great Britain market and needs to confirm whether it must register with the MHRA, whether a UK Responsible Person is required and whether CE or UKCA positioning is acceptable for the target route. [page:1][page:2] |
Typical Users
Different actors approach UK registration from different positions, but all need a defensible answer on territory, conformity and registration obligations.
| UK-Based Manufacturer | Needs to register the device with the MHRA before Great Britain placement and maintain accurate registration data. [page:1][page:2] |
| Non-UK Manufacturer | Needs to appoint a single UK Responsible Person to act on its behalf for Great Britain registrations. [page:1][page:2] |
| UK Responsible Person | Needs to hold the written mandate and carry out specified regulatory tasks for represented manufacturers. [page:2] |
| Regulatory Affairs Lead | Needs to align classification, conformity, documentation and territory-specific registration strategy. |
| Importer or Distributor | Needs to understand whether importer-notification and registration-support rules affect the commercial model. [page:1][page:2] |
Typical Scenarios
Practical scenarios illustrate where the UK registration analysis becomes important in real market-entry work.
| Great Britain Launch | The business needs to register with the MHRA before placing the device on the market in England, Wales or Scotland. [page:1][page:2] |
| Non-UK Entry | The manufacturer must appoint a single UK Responsible Person for Great Britain before the device can be registered and placed on that market. [page:1][page:2] |
| Northern Ireland Review | The business must determine whether Northern Ireland follows EU-facing requirements, MHRA registration, EUDAMED registration or an EU/NI authorised representative structure for the relevant scenario. [page:1][page:2] |
| Conformity Strategy | The company must assess whether its Great Britain route relies on UKCA marking, CE marking during the recognised transition period, or a mixed planning approach. [page:2] |
| Portfolio Update | The business needs to update registrations and ensure all information with the MHRA remains accurate and up to date. [page:1] |
| Importer Setup | A Great Britain importer must notify the relevant manufacturer or UK Responsible Person of its intention to import, and importer details must then be submitted to the MHRA in the relevant cases. [page:1][page:2] |
Jurisdiction Characteristics
The United Kingdom is a territory-split device jurisdiction with the MHRA as the central regulator for the UK market, but with different operational pathways for Great Britain and Northern Ireland. [page:2]
The most important commercial characteristic is that Great Britain requires pre-placement registration with the MHRA for all medical devices, while Northern Ireland follows a different structure tied to EU rules and changing registration mechanics. The MHRA guidance states that from 28 May 2026, all medical devices other than custom-made devices must be registered on EUDAMED prior to placement on the EU and Northern Ireland markets, after which MHRA registration will not be required for those products in that context. [page:1]
| Operational Culture | MHRA-centered, territory-sensitive and documentation-dependent. |
| Legal Framework Orientation | UK MDR 2002 for Great Britain, with Northern Ireland operating under a different structure involving EU rules in relevant cases. [page:1][page:2] |
| Commercial Context | Major health-technology market requiring careful planning for conformity marking, representative structure and registration. |
| Language Expectation | English-language regulatory and commercial operation is standard. |
Key Authorities
UK medical device registration is centered on the Medicines and Healthcare products Regulatory Agency. The MHRA states that it is responsible for regulating the UK medical devices market. [page:2]
| Official Name | Medicines and Healthcare products Regulatory Agency |
| Official English Name | Medicines and Healthcare products Regulatory Agency (MHRA) |
| Primary Role | UK authority responsible for regulating the medical devices market. [page:2] |
| Responsibilities | Regulates the market, performs market surveillance, administers registration functions and oversees conformity-assessment body designation in relevant UK structures. [page:1][page:2] |
| Typical Interaction | Direct where a business registers devices, updates device information, responds to scrutiny requests or engages on territory-specific route-to-market questions. |
| Official Website | MHRA UK Medical Devices Guidance |
| Cross-Border Relevance | High, because foreign manufacturers targeting Great Britain must engage the UK Responsible Person and MHRA registration framework. [page:1][page:2] |
Applicable Legislation
The UK legal structure combines the UK Medical Devices Regulations framework with MHRA guidance on registration, conformity and territorial application. The MHRA states that devices in Great Britain are regulated under the Medical Devices Regulations 2002 (SI 2002 No 618, as amended), referred to as the UK MDR 2002. [page:1][page:2]
| Official Title | Medical Devices Regulations 2002 (SI 2002 No 618, as amended) |
| Year | 2002, as amended |
| Purpose | Provides the core legal framework for medical devices in Great Britain. [page:1][page:2] |
| Typical Application | Used to determine conformity, registration and representative obligations for devices placed on the Great Britain market. [page:1][page:2] |
| Related Legislation | Northern Ireland Regulations 2021, EU MDR and EU IVDR in Northern Ireland scenarios, and transitional acceptance rules for CE-marked devices. [page:1][page:2] |
| Official Source | Regulating medical devices in the UK |
| Current Status | Active framework for Great Britain. [page:2] |
| Official Title | MHRA Registration Guidance for Medical Devices |
| Year | Current guidance updated 8 July 2026 |
| Purpose | Explains how devices must be registered with the MHRA and what information and fees apply. [page:1] |
| Typical Application | Used by manufacturers and UK Responsible Persons to complete registration and maintain account accuracy. [page:1] |
| Related Legislation | UK MDR 2002, Northern Ireland rules and MHRA fee rules. [page:1][page:2] |
| Official Source | Register medical devices to place on the market |
| Current Status | Active MHRA guidance. [page:1] |
Process Flow
UK medical device registration generally works as a staged process from product qualification through territory analysis, conformity route selection, representative setup and registration. The MHRA explains that manufacturers placing devices on the Great Britain market need to register with the MHRA, comply with marking and conformity requirements and, if based outside the UK, appoint a UK Responsible Person. [page:2]
| 1. Product Qualification | Confirm that the product qualifies as a medical device or IVD in the relevant UK framework. [page:1] |
| 2. Territory Mapping | Determine whether the target market is Great Britain, Northern Ireland or both. [page:1][page:2] |
| 3. Classification and Conformity Review | Identify the relevant class and whether the route relies on self-certification, UK Approved Body involvement, CE positioning or other applicable conformity logic. [page:2] |
| 4. Representative Structure | Appoint a UK Responsible Person where the manufacturer is outside the UK and the Great Britain market is targeted. [page:1][page:2] |
| 5. Documentation Readiness | Prepare declaration of conformity, technical documentation, certificates or self-certification records as applicable. [page:1][page:2] |
| 6. DORS Account Setup | Create an account on the Device Online Registration System before registration work begins. [page:1] |
| 7. MHRA Registration | Register the device with the MHRA before Great Britain placement where required. [page:1][page:2] |
| 8. Importer and Labelling Alignment | Ensure importer details and UK Responsible Person labelling obligations are addressed where relevant. [page:1][page:2] |
| 9. Market Placement | Place the device on the relevant UK market only after the correct registration and conformity position is in place. |
| 10. Ongoing Maintenance | Review and update registrations as legal and commercial facts change. [page:1] |
Decision Tree
The decision tree helps simplify the main UK threshold questions.
- Confirm whether the product qualifies as a medical device or IVD in the UK framework. [page:1]
- Determine whether the target market is Great Britain, Northern Ireland or both. [page:1][page:2]
- For Great Britain, confirm whether the device can rely on CE positioning during the recognised transition period or requires or prefers UKCA positioning. [page:2]
- Identify whether a UK Approved Body is needed or whether self-certification is available for the device class. [page:2]
- If the manufacturer is outside the UK and Great Britain is targeted, appoint a single UK Responsible Person. [page:1][page:2]
- Prepare the registration dataset, including manufacturer and device details, conformity documents and GMDN-based information where applicable. [page:1]
- Register via DORS and wait for confirmation before assuming the device is registered. The MHRA states that a business is not regarded as registered until device details have been provided and confirmation has been received. [page:1]
- Keep the registration accurate and updated, since the MHRA states that registered information must remain accurate and up to date. [page:1]
Timeline
The UK timeline starts before launch and continues after market placement. For Great Britain, registration is a pre-placement requirement and must be completed before the device is placed on the market. [page:1][page:2]
| Concept Stage | The business defines the product, territory target and commercial route. |
| Qualification Stage | The product is checked against the UK medical-device definition. [page:1] |
| Territory Strategy Stage | The business distinguishes Great Britain, Northern Ireland or dual-market strategy. [page:1][page:2] |
| Conformity Stage | The company confirms UKCA, CE or other applicable conformity basis and any third-party assessment requirements. [page:2] |
| Representative Stage | Where relevant, the UK Responsible Person is appointed for Great Britain. [page:1][page:2] |
| Registration Stage | The device is registered with the MHRA through DORS before Great Britain market placement. [page:1][page:2] |
| Launch Stage | The device is placed on the relevant market only after the legal route is complete. |
| Maintenance Stage | The registration is reviewed and updated as changes occur. [page:1] |
Required Documents
The exact document set depends on the device and target territory, but UK medical device registration depends on a coherent file set that supports conformity, representation and registration.
| Document | Product Qualification Record |
| Purpose | Shows why the product qualifies as a medical device or IVD in the UK framework. [page:1] |
| Typical Situation | Prepared at the beginning of UK market-entry planning. |
| Document | Declaration of Conformity and Technical Documentation |
| Purpose | Supports conformity with the applicable framework, including inspection-readiness for the MHRA. [page:2] |
| Typical Situation | Used before market placement and in support of registration or MHRA requests. [page:1][page:2] |
| Document | UK Responsible Person Letter of Designation |
| Purpose | Provides the legal mandate appointing the exclusive UK Responsible Person where applicable. [page:1] |
| Typical Situation | Needed where a manufacturer based outside the UK targets the Great Britain market. [page:1][page:2] |
| Document | Device Registration Dataset |
| Purpose | Contains device class, GMDN code and term, name, model/version, UDI information where applicable, certificates and attributes. [page:1] |
| Typical Situation | Used for MHRA registration submissions in DORS. [page:1] |
| Document | Importer and Labelling Position Record |
| Purpose | Confirms whether importer details and UK Responsible Person labelling are correctly addressed. [page:1][page:2] |
| Typical Situation | Used when the supply chain involves Great Britain importation or UKCA-marked products. [page:2] |
Cross-Border Relevance
Cross-border relevance is high because many non-UK manufacturers use the UK as a target market. The MHRA states that manufacturers based outside the UK must appoint a single UK Responsible Person to place devices on the Great Britain market. [page:1][page:2]
The cross-border challenge is amplified by the fact that Great Britain and Northern Ireland do not operate as a single route-to-market territory for devices. A foreign manufacturer may need one structure for Great Britain and another for Northern Ireland or the EU-facing pathway, depending on the product and target geography. [page:1][page:2]
| Recognition | The UK does not operate as a single uniform registration space for all device placements; Great Britain and Northern Ireland must be assessed separately. [page:1][page:2] |
| Foreign Companies | Non-UK manufacturers targeting Great Britain must appoint a UK Responsible Person. [page:1][page:2] |
| Language Considerations | English is the core operating language for the relevant regulatory documentation and communications. |
| International Rules | Cross-border businesses must align conformity marking, representative structure and registration route with the target UK territory. [page:1][page:2] |
| Practical Considerations | Many failures arise when businesses assume CE status, UKCA status and MHRA registration operate identically across all UK territories. |
| Typical Risk | Launching in Great Britain without MHRA registration, or relying on the wrong representative structure for the relevant UK territory. [page:1][page:2] |
MHRAUK Responsible PersonDORSUKCACEGreat BritainNorthern Ireland
Operating Constraints & Risks
Operating constraints identify the most common failure points in UK medical device registration. Many of them come from treating the UK as a single rule block or from confusing registration with product endorsement.
| Territory Risk | The business fails to distinguish Great Britain from Northern Ireland and applies the wrong route. [page:1][page:2] |
| Representative Risk | A non-UK manufacturer targets Great Britain without appointing a single UK Responsible Person. [page:1][page:2] |
| Registration Risk | The device is placed on the Great Britain market before MHRA registration is complete. [page:1][page:2] |
| Approval Language Risk | The company incorrectly presents MHRA registration as approval, certification or endorsement, which MHRA guidance forbids. [page:1] |
| Data Accuracy Risk | Registered information is incomplete or not kept up to date even though the MHRA requires accuracy and timely updates. [page:1] |
| Conformity Risk | The wrong conformity basis is chosen, or UKCA and CE transition rules are misunderstood. [page:2] |
| Change-Control Risk | Regulatory or product changes occur without checking whether re-registration or fee-triggering updates are required. [page:1] |
Costs & Fees
UK medical device registration costs arise from more than one step. Businesses must consider conformity work, representative costs, registration operations and the MHRA fee structure.
| Conformity Costs | Technical documentation, assessment work and, where needed, UK Approved Body involvement can create material cost. [page:2] |
| Representative Costs | Non-UK manufacturers usually incur commercial costs associated with appointing and maintaining a UK Responsible Person. |
| Registration Fees | The MHRA states that a new fee structure took effect on 1 April 2026, with annual charging based on Level 2 GMDN categories. [page:1] |
| Current Unit Fee Reference | The MHRA states that from 1 April 2026 to 31 March 2027 the unit cost is £300 per year per Level 2 GMDN category, or Level 1 where no Level 2 exists. [page:1] |
| Change Fees | Some updates and re-registrations may trigger statutory fees depending on the type of change. [page:1] |
| Maintenance Costs | Ongoing account review, registration upkeep and regulatory maintenance create continuing cost. [page:1] |
FAQ
The FAQ section addresses recurring threshold questions in UK market-entry work.
| Do All Devices Need MHRA Registration for Great Britain? | Yes. The MHRA states that all medical devices, including IVDs, custom-made devices and systems or procedure packs, must be registered before they are placed on the Great Britain market. [page:1][page:2] |
| Is MHRA Registration the Same as Approval? | No. MHRA guidance states that registration does not represent accreditation, certification, approval or endorsement. [page:1] |
| Does a Non-UK Manufacturer Need a UK Responsible Person? | Yes for Great Britain. The MHRA states that non-UK manufacturers placing devices on the Great Britain market must appoint a single UK Responsible Person. [page:1][page:2] |
| Can CE-Marked Devices Still Be Placed on the Great Britain Market? | Yes, within the current recognition timelines identified by MHRA guidance, which in some cases extend to 30 June 2028 or 30 June 2030 depending on device type and legislation. [page:2] |
| Does Northern Ireland Follow the Same Rules as Great Britain? | No. The MHRA states that different rules apply in Northern Ireland. [page:2] |
| Is a Business Registered As Soon As It Creates a DORS Account? | No. The MHRA states that you are not regarded as registered until device details have been provided and confirmation has been received. [page:1] |
Practical Guidance
Practical guidance helps a business prepare before filing or finalising a UK launch strategy.
| Checklist | What exactly is the product and does it meet the UK medical-device definition? Is the target market Great Britain, Northern Ireland or both? What device class and conformity route apply? Is the device relying on UKCA, CE or another permitted territorial basis? If Great Britain is targeted by a non-UK manufacturer, has a single UK Responsible Person been appointed? Are the declaration of conformity, technical documentation and certificates ready? Has the DORS registration dataset been prepared with correct manufacturer details, GMDN terminology, device names, model/version data and attributes? Is the business aware that MHRA registration is not endorsement? Have ongoing update and fee implications been mapped? |
A disciplined UK registration review should start with territory and representative structure. In many failed launches, the apparent registration problem is actually a prior error about whether the business was targeting Great Britain or Northern Ireland, or whether the correct person was appointed to register the device. [page:1][page:2]
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-UK-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration United Kingdom |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | United Kingdom medical device registration with emphasis on MHRA registration, UK Responsible Person structure, conformity positioning and Great Britain versus Northern Ireland rules. |
| Registry Reference | MAR-UK-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration united kingdom uk great britain northern ireland mhra uk responsible person ukca ce dors uk mdr 2002 device registration conformity market access |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in the United Kingdom, including MHRA registration, UK Responsible Person requirements, UKCA and CE positioning, Great Britain and Northern Ireland distinctions and DORS-based registration workflow. |
| Entity Index | United Kingdom Medical Device Registration MHRA UK Responsible Person UKCA CE Great Britain Northern Ireland DORS UK MDR 2002 |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID UK.MDR.001 | Machine Reference MAR-UK-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > United Kingdom | Checksum 0xMDR82UK |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |